These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 26164355)
1. Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries. Ignatyeva O; Balabanova Y; Nikolayevskyy V; Koshkarova E; Radiulyte B; Davidaviciene E; Riekstina V; Jaama K; Danilovits M; Popa CM; Drobniewski FA Tuberculosis (Edinb); 2015 Sep; 95(5):581-8. PubMed ID: 26164355 [TBL] [Abstract][Full Text] [Related]
2. Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections. Viveiros M; Martins M; Couto I; Rodrigues L; Machado D; Portugal I; Amaral L Expert Rev Anti Infect Ther; 2010 Apr; 8(4):465-80. PubMed ID: 20377340 [TBL] [Abstract][Full Text] [Related]
3. Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Abubakar I; Moore J; Drobniewski F; Kruijshaar M; Brown T; Yates M; Anderson C; Smith EG; Magee J; Lipman M; McMenamin J; Ruddy M; Watson JM Thorax; 2009 Jun; 64(6):512-5. PubMed ID: 19318348 [TBL] [Abstract][Full Text] [Related]
4. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis. Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036 [TBL] [Abstract][Full Text] [Related]
5. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416 [TBL] [Abstract][Full Text] [Related]
7. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
8. New treatment options for multidrug-resistant tuberculosis. Field SK; Fisher D; Jarand JM; Cowie RL Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of drug resistance in Mycobacterium tuberculosis. Zhang Y; Yew WW Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002 [TBL] [Abstract][Full Text] [Related]
10. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease? Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321 [No Abstract] [Full Text] [Related]
11. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Leimane V; Riekstina V; Holtz TH; Zarovska E; Skripconoka V; Thorpe LE; Laserson KF; Wells CD Lancet; 2005 Jan 22-28; 365(9456):318-26. PubMed ID: 15664227 [TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries. Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038 [No Abstract] [Full Text] [Related]
13. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease]. Baylan O Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173 [TBL] [Abstract][Full Text] [Related]
14. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones. Chiang CY Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001 [No Abstract] [Full Text] [Related]
15. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance. Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359 [TBL] [Abstract][Full Text] [Related]
16. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update. Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012 [TBL] [Abstract][Full Text] [Related]
17. Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia. Balabanova Y; Nikolayevskyy V; Ignatyeva O; Kontsevaya I; Rutterford CM; Shakhmistova A; Malomanova N; Chinkova Y; Mironova S; Fedorin I; Drobniewski FA PLoS One; 2011; 6(6):e20531. PubMed ID: 21695213 [TBL] [Abstract][Full Text] [Related]
18. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Shah NS; Richardson J; Moodley P; Moodley S; Babaria P; Ramtahal M; Heysell SK; Li X; Moll AP; Friedland G; Sturm AW; Gandhi NR Emerg Infect Dis; 2011 Mar; 17(3):510-3. PubMed ID: 21392446 [TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM; Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911 [No Abstract] [Full Text] [Related]